Showing 6151-6160 of 20929 results for "".
- Pediatric Vaccination Strategies: Navigating SARS-CoV-2 Variant Challenges for 2025–26https://reachmd.com/news/pediatric-vaccination-strategies-navigating-sars-cov-2-variant-challenges-for-202526/2474968/As SARS-CoV-2 continues to evolve, pediatric vaccination strategies face underrecognized challenges that will shape the 2025–26 immunization landscape. The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) conv
- Addressing Copathologies in Alzheimer's Diseasehttps://reachmd.com/news/addressing-copathologies-in-alzheimers-disease/2474969/Understanding the nuanced landscape of Alzheimer’s requires recognizing and addressing copathologies that significantly influence symptom severity and disease progression, as underscored by
- Evolving Role of Therapeutic Hypothermia in TBI: Modulating Tau Protein Dynamics for Enhanced Neuroprotectionhttps://reachmd.com/news/evolving-role-of-therapeutic-hypothermia-in-tbi-modulating-tau-protein-dynamics-for-enhanced-neuroprotection/2474981/Therapeutic hypothermia is emerging as a pivotal intervention in TBI treatment by directly targeting tau protein dynamics to limit neuronal damage and enhance neuro-recovery. Neurologists and neurointensivists continue to confront the
- Optimizing Botulinum Toxin Formulations for Fast and Lasting Cosmetic Resultshttps://reachmd.com/news/optimizing-botulinum-toxin-formulations-for-fast-and-lasting-cosmetic-results/2474980/Demand for rapid and enduring cosmetic improvements is driving dermatologists to refine their selection of botulinum toxin formulations in glabellar line treatments. Given patient expectations for visible results, practitioners in Cosm
- Pivekimab Sunirine: A New Hope for BPDCN Treatmenthttps://reachmd.com/news/pivekimab-sunirine-a-new-hope-for-bpdcn-treatment/2474977/BPDCN remains an aggressive rare blood cancer with limited treatment options, and the introduction of Pivekimab Sunirine may influence outcomes for this challenging condition. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is mar
- Genetic Breakthroughs in Retinal Disease: Revolutionizing Diagnosis and Therapyhttps://reachmd.com/news/genetic-breakthroughs-in-retinal-disease-revolutionizing-diagnosis-and-therapy/2474975/Ongoing breakthroughs in genetic research are poised to revolutionize the diagnosis and management of inherited retinal diseases, with the University of Oklahoma spearheading efforts that promise to redefine molecular diagnostics and pave the
- Probiotic for Oily and Acne-Prone Skin Gets US Patenthttps://reachmd.com/news/Probiotic-Oily-Acne-Prone-Skin-Gets-US-Patent/2474976/A probiotic for managing oily, acne-prone skin was awarded US Patent No. 12,194,068, Codex Labs announced. In an independent clinical trial at Integrative Skin Solutions Research involving 18 male and female subjects with mild to moderate acne, the measured improvement after 8 weeks of Cod
- Navigating Regulatory Shifts in Anesthesiology: Business Models vs. Market Fairnesshttps://reachmd.com/news/navigating-regulatory-shifts-in-anesthesiology-business-models-vs-market-fairness/2474936/Recent regulatory actions are transforming the competitive landscape in anesthesiology, spotlighting the tension between business practices and market fairness. As oversight intensifies, healthcare administrators and policy makers conf
- AI Tools to Mitigate Emergency Department Overcrowdinghttps://reachmd.com/news/ai-tools-to-mitigate-emergency-department-overcrowding/2474938/Emergency Department overcrowding endures as a pervasive bottleneck in acute care, driving prolonged waits and eroding staff capacity to deliver timely interventions. This tension is compounded by complex social and medical needs, lega
- Moral Distress in Pediatric Mental Health Care: Challenges and Solutionshttps://reachmd.com/news/moral-distress-in-pediatric-mental-health-care-challenges-and-solutions/2474940/Pediatricians are increasingly confronted with moral distress as they strive to meet growing mental health needs against a backdrop of resource scarcity and limited training. The challenges in providing pediatric mental health care are